A Study to Test if TEV-50717 is Safe and Effective in Relieving Abnormal Involuntary Movements in Cerebral Palsy
Clinical trial NCT04200352 · TERMINATED
Trial details
- NCT number
- NCT04200352
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-04
- Primary completion
- 2023-02-14
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.